
3rd Annual DMPK Symposium
Pharmaron’s 3rd Pharmaron Symposium on DMPK was held at our Beijing site on June 22, 2024. Recognizing the importance of DMPK science to drug discovery and development, this DMPK symposium is our commitment to staff education and development and to ensure we continuously evolve our science and remain connected to our partners.
The Beijing site was transformed for the day with a DMPK science evolution and integration theme. The team welcomed distinguished international speakers and key opinion leaders from academia, biotech, and pharma. Subject matters covered the latest developments with in vitro parameter extrapolation and PBPK modeling, translational PKPD modeling, model-informed precision dosing, novel human model systems, and the evolving role of the bioanalytical scientist.
- Prof. Yuichi Sugiyama, Josai International University, Japan
- Prof. Amin Rostami-Hodjegan, University of Manchester, UK
- Dr. Neil Benson, Director, Quantlmed Ltd., UK
- Dr. Sylvia Zhao, Vice President, Roche, China
- Prof. Dongyang Liu, Peking University Third Hospital, China
- Ms. Faye Vazvaei-Smith, Executive Director, Merck, US
Over 300 employees attended the meeting, including a networking poster session featuring 30 posters on in vitro, in vivo, modeling, and bioanalytical topics across multiple modalities.
We thank all the speakers and organizing committee and look forward to the 4th Pharmaron Symposium on DMPK.
To learn more about DMPK science, read about our DMPK services.